{"Name":"SuperGen","perma":"supergen","BasicInfo":{"funded":"1991-01-01","isClosed":false,"closed":null,"short":"SuperGen operates a pharmaceutical compnay dedicated to the research and discovery of oncological drug therapy."},"FundingRounds":[{"funding_type":"venture","series":null,"announcedDate":"2009-10-22","moneyRaised":3000000},{"funding_type":"venture","series":null,"announcedDate":"1999-11-19","moneyRaised":7600000}],"Acquisitions":[{"price":55000000,"paymentType":"cash_and_stock","announcedDate":"2011-04-07","acquireeName":"Astex"}],"AcquiredBy":null,"IPO":null,"Investments":[],"Products":[],"CurrentTeam":[],"PastTeam":[{"title":"Team Member","started":null,"ended":null,"firstName":"Sam","lastName":"Boddapati"},{"title":"Head of Clinical Development and Chief Medical Officer","started":"2006-01-01","ended":"2009-01-01","firstName":"Greg","lastName":"Berk"}]}
